03878nam 22006855 450 991037391800332120220601190847.0981-329-628-310.1007/978-981-32-9628-2(CKB)4100000009837049(DE-He213)978-981-32-9628-2(MiAaPQ)EBC5976180(PPN)260303909(EXLCZ)99410000000983704920191111d2019 u| 0engurnn#008mamaatxtrdacontentcrdamediacrrdacarrierTherapeutic Vaccines as Novel Immunotherapy Biological and Clinical Concepts /edited by Hironori Nakagami1st ed. 2019.Singapore :Springer Singapore :Imprint: Springer,2019.1 online resource (VII, 79 p. 14 illus., 9 illus. in color.)981-329-627-5 Includes bibliographical references.Chapter 1.Overview about the concept of therapeutic vaccine -- Chapter 2.Immunotherapy for Tau and amyloid beta against Alzheimer disease -- Chapter 3.Therapeutic vaccine for cardiovascular diseases -- Chapter 4.Immunotherapy for obesity -- Chapter 5.Immunotherapy for spondyloarthritis -- Chapter 6.Recent progress of DNA vaccine -- Chapter 7.Translational research of novel peptide vaccine -- Chapter 8.Conclusion.This book offers an excellent introduction to the use of novel therapeutic vaccines for common diseases based on their ability to induce antibody production. While the role of vaccines in the treatment of infectious diseases and cancer is well known, vaccines have also recently been developed for a variety of other conditions, including Alzheimer’s disease, hypertension, diabetes, and spondyloarthritis. These therapeutic advances are fully and clearly documented by acknowledged experts in the field, who explain the relevant biology and highlight the challenges involved in deploying this treatment approach effectively and safely. In addition, recent progress in the construction and delivery of DNA vaccines is documented, and the process of developing new peptide vaccines is explored in depth. While the book will be particularly valuable for researchers and scholars interested in immunotherapy, it will also appeal to clinicians seeking effective new medicines to treat patients suffering from chronic diseases.ImmunologyPharmaceutical technologyMedicineVaccinesDrug resistanceImmunologyhttps://scigraph.springernature.com/ontologies/product-market-codes/B14000Pharmaceutical Sciences/Technologyhttps://scigraph.springernature.com/ontologies/product-market-codes/B21010Medicine/Public Health, generalhttps://scigraph.springernature.com/ontologies/product-market-codes/H00007Vaccinehttps://scigraph.springernature.com/ontologies/product-market-codes/B16010Drug Resistancehttps://scigraph.springernature.com/ontologies/product-market-codes/B16020VacunesthubLlibres electrònicsthubImmunology.Pharmaceutical technology.Medicine.Vaccines.Drug resistance.Immunology.Pharmaceutical Sciences/Technology.Medicine/Public Health, general.Vaccine.Drug Resistance.Vacunes616.079Nakagami Hironoriedthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910373918003321Therapeutic Vaccines as Novel Immunotherapy2230342UNINA